The 20 Best Tieche-Jadassohn Nevus Doctors Near Me in Ann Arbor, MI

After receiving my M.D. and Ph.D. at the University of Alabama at Birmingham, I came to the University of Michigan for residency training in Anatomic Pathology. During my residency and subsequent Dermatopathology fellowship, I became interested in mechanistic studies of cutaneous and soft-tissue malignancies. Upon completion of my fellowship in June 2012, I accepted a faculty position at UMHS with joint appointments in the Departments of Dermatology and Pathology, in which I continue to investigate molecular events in the pathogenesis of Merkel cell carcinoma and other cutaneous malignancies, while maintaining clinical effort in dermatopathology and molecular dermatopathology. Dr. Harms is rated as an Elite provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Merkel Cell Carcinoma, Tieche-Jadassohn Nevus, Melanoma, and Sebaceous Adenoma. Dr. Harms is board certified in Pathology-Anatomic and Dermatopathology.

Aleodor Andea is a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Andea is rated as an Elite provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Tieche-Jadassohn Nevus, Melanoma, Syringoma, and Basal Cell Skin Cancer.

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as an Advanced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Lowe received her undergraduate degree from Occidental College, Los Angeles, California in 1981 and her M.D. degree from the University of Texas Medical School at Houston, Houston, Texas in 1985. She did a transitional internship at St. Joseph's Hospital, Houston, Texas from 1985-1986 and then was a Post-doctoral Fellow in the Department of Dermatology at the University of Texas Medical School at Houston. From 1987-1989, she completed her residency training in dermatology at the University of Texas Medical School at Houston, followed by a Dermatopathology Fellowship at the University of Colorado School of Medicine, Denver, Colorado, from 1990-1991. Dr. Lowe is board certified in both Dermatology and Dermatopathology.In 1990, Dr. Lowe served as an Instructor in the Department of Dermatology at the University of Texas Medical School at Houston, Houston, Texas. She moved to the Department of Dermatology at Henry Ford Hospital, Detroit, Michigan, where she was a Senior Staff Physician and Director of Dermatopathology from 1991-1996. In 1996 she joined the faculty of the Departments of Pathology and Dermatology at the University of Michigan Medical School, Ann Arbor, Michigan, as Assistant Professor, where she was promoted to Associate Professor in 1998, and to Professor in 2004. She served as the Director of Dermatopathology in the Department of Pathology from 1996-2012.While at the University of Michigan Medical School, Dr. Lowe has been actively involved in the dermatopathology service, teaching and academic pursuits. She has been recognized institutionally and nationally as an educator and clinician. In 2013, Dr. Lowe received the Walter Nickel Teaching Award given by the American Society of Dermatopathology and also received the Outstanding Clinician of the Year Award bestowed by the University of Michigan Medical School. In 2015, she was inducted into the University of Michigan League of Clinical Excellence. Dr. Lowe received the William B. Taylor Resident Teaching Award from the Department of Dermatology, University of Michigan in 1999 and 2005 for exemplary teaching. She has been recognized annually since 2003 in America's Top Doctors for Cancer by Castle Connolly Medical Ltd. She has served on national committees, including the American Board of Dermatology, Dermatopathology Test Committee and the American Board of Pathology, Dermatopathology Test Committee and has served on the editorial boards of both the Journal of the American Academy of Dermatology and Cancer. Dr. Lowe is the author or co-author of more than 130 publications in peer-reviewed journals. Dr. Lowe is rated as an Advanced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Sebaceous Adenoma, Syringoma, and Syringocystadenoma Papilliferum. Dr. Lowe is board certified in Dermatology and Dermatopathology.

Dr. Kelly Harms, MD, PhD, is a faculty member in the Department of Dermatology at the University of Michigan and the director of our Multi-disciplinary Cutaneous Oncology clinic. She provides patient care in our Cutaneous Surgery and Oncology clinical programs, including the Mohs surgery clinic and multidisciplinary melanoma and cutaneous oncology clinics located within the U-M Rogel Cancer Center. Dr. Harms is a board-certified dermatologist and ACGME Fellowship-trained Mohs Surgeon, with specialized training and expertise in treating high-risk skin cancer.Dr. Harms joined the Dermatology faculty in 2014, upon completing her ACGME procedural dermatology fellowship, with advanced training in melanoma and cutaneous surgery and oncology at the Rogel Cancer Center. Her clinical work is focused on Mohs surgery and associated reconstruction, as well as the complex management of patients seen within our Multidisciplinary Melanoma and Merkel Cell Programs.Dr. Harms received her medical degree from the University of Alabama School of Medicine and her Ph.D. degree from the Medical Scientist Training Program in the Department of Cell Biology at the University of Alabama at Birmingham. She completed her internship in the Department of Internal Medicine, University of Michigan Hospitals. She completed her dermatology residency, post-doctoral research training, and procedural dermatology fellowship in the Department of Dermatology, University of Michigan Medical School. Her clinical research is focused on skin cancer biology and epidemiology, and therapy. Dr. Harms is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Melanoma, Eccrine Porocarcinoma, and Basal Cell Skin Cancer. Dr. Harms is board certified in Dermatology and Micrographic Dermatologic Surgery.

Hakan Demirci is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Demirci is rated as an Advanced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Retinoblastoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Vitrectomy.

Stephen Sullivan, M.D., is a graduate of the University of Chicago Pritzker School of Medicine and is board certified in Neurosurgery. He is director of the Pituitary Clinic. His clinical and research interests pertain to the treatment of pituitary tumors, Cushing’s disease and acromegaly. Dr. Sullivan is rated as an Advanced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Pituitary Tumor, Chordoma, Balloon Sinuplasty, and Awake Craniotomy. Dr. Sullivan is board certified in Neurological Surgery.

Khaled Hafez is a Urologist practicing medicine in Ann Arbor, Michigan. Dr. Hafez is rated as an Advanced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Hafez is board certified in Urology.

Dr. May Chan obtained her medical degree from the State University of New York at Buffalo and was a Howard Hughes Research Scholar in 2005-2006. She completed residency training in Anatomic Pathology at Beth Israel Deaconess Medical Center in Boston, followed by a Dermatopathology fellowship at Harvard. She joined the University of Michigan in 2011 and is now a Professor of Pathology and Dermatology. She is the Interim Section Head for Dermatopathology, the Program Director for the Dermatopathology Fellowship, and the Medical Director of the Immunohistochemistry Laboratory. She also serves on the Test Development and Advisory Committee of the American Board of Pathology.Dr. Chan is an editorial board member of Modern Pathology and Journal of Cutaneous Pathology. She has a broad research interest in the areas of inflammatory skin diseases, melanocytic lesions, cutaneous adnexal neoplasms, and immunohistochemistry. She is the author/co-author of over 90 peer-reviewed publications and the book, Handbook of Direct Immunofluorescence: A Pattern-based Approach to Skin and Mucosal Biopsies.Dr. Chan is board certified in Anatomic Pathology and Dermatopathology. In addition to her primary role as a dermatopathologist, Dr. Chan retains her interest in surgical pathology including interpretation of head and neck, soft tissue, pulmonary, and endocrine cases, as well as intraoperative frozen sections. Over the years she has been invited to speak at national and international meetings hosted by the United States and Canadian Academy of Pathology (USCAP), the American Society of Dermatopathology (ASDP), the College of American Pathologists (CAP), the American Society for Clinical Pathology (ASCP), the American Academy of Dermatology (AAD), the European Nail Society, and Dermpedia. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Basal Cell Skin Cancer, Sebaceous Adenoma, and Squamous Cell Skin Carcinoma.

Dr. Breglio is a Clinical Instructor and board-certified dermatologist in the Department of Dermatology at the University of Michigan. Dr. Breglio obtained her Doctor of Medicine degree at Penn State College of Medicine. She obtained her Doctor of Philosophy degree at University of Oxford through the NIH Oxford Cambridge Scholars Program. She completed her dermatology residency training at Duke University Medical Center. She then practiced at the Durham VA Medical Center, Greenville VA Medical Center, and as Adjunct Assistant Professor in the Duke Dermatology Department. She came to University of Michigan for a Micrographic Surgery and Dermatologic Oncology Fellowship. Dr. Breglio is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. Her clinical expertise encompasses Tieche-Jadassohn Nevus, Basal Cell Skin Cancer, Dermatomyositis, and Marginal Zone Lymphoma (MZL). Dr. Breglio is board certified in Dermatology.

Mehboob Hussain is an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Hussain is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. His clinical expertise encompasses Autosomal Dominant Hypocalcemia, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Tieche-Jadassohn Nevus.

David N. Zacks completed his undergraduate degree at Cornell University, where he majored in neurobiology. This was followed by a combined M.D. and Ph.D. from the Albert Einstein College of Medicine in Bronx, New York. He finished his ophthalmology residency in 2000 and his vitreo-retinal fellowship in 2002, both at the Massachusetts Eye and Ear Infirmary in Boston, Massachusetts. Dr. Zacks joined the Retina Service of the University of Michigan’s Kellogg Eye Center in 2002. His clinical activity focuses on diseases and surgery of the retina. His main research interest is in the molecular control of photoreceptor cell death during retinal disease. He holds (or has held) research grants from the National Eye Institute, Research to Prevent Blindness, Inc., Foundation Fighting Blindness, Midwest Eye Bank and Transplantation Center, as well as other foundations. Dr. Zacks has received numerous honors and is a member of various societies, including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the Retina Society, the Macula Society and the American Society of Retina Specialists. Dr. Zacks is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Artery Occlusion, and Vitrectomy. Dr. Zacks is board certified in Ophthalmology.

Manjool Shah is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Cataract, Trabeculectomy, and Cataract Removal. Dr. Shah is board certified in Ophthalmology.

Dr. Jennifer Weizer completed her undergraduate education at Columbia University and The Juilliard School. After completing medical school at Baylor College of Medicine in Houston, Texas, she received her residency training in ophthalmology and completed a glaucoma fellowship at Duke University Eye Center in Durham, North Carolina.Following her training, Dr. Weizer joined the University of Michigan Medical School faculty as an Assistant Professor of Ophthalmology and Visual Sciences in 2005. She practices at the Kellogg Eye Center Glaucoma Clinic, where she diagnoses, manages and treats patients with glaucoma both medically and surgically. She also specializes in the surgical management of cataracts in patients with glaucoma. Her clinical and research interests involve early detection of glaucoma, nerve fiber layer and optic nerve evaluation, healthcare guidelines and compliance, and quality improvement in healthcare. Dr. Weizer is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Vitrectomy. Dr. Weizer is board certified in Ophthalmology.

Grant M. Comer, M.D., specializes in diseases and surgery of the retina and vitreous, including diagnosis and treatment of ocular melanoma retinal detachments, diabetic retinopathy, age-related macular degeneration (AMD), retinal vascular disease, ocular trauma, infectious chorioretinitis, and surgical management of complex retinal detachments.His research interests range from developing alternative treatment regimens for retinal diseases, including AMD and endophthalmitis, to studying the cost-effectiveness of vitreoretinal care and maximizing patient satisfaction through multimedia-based patient education.Dr. Comer received his medical degree from Indiana University in 2001. Following an internship at Methodist Hospital in Indianapolis, he completed a residency in ophthalmology at IU in 2005. From 205 to 2007 he undertook a vitreoretinal, uveitis and ocular oncology fellowship at the University of Michigan Kellogg Eye Center, and served as a clinical lecturer in the Department of Ophthalmology and visual Sciences from 2005 to 2009. In 2009, he earned a Master of Science in clinical research design and statistical analysis from the University of Michigan’s School of Public Health. His bibliography reflects 12 peer-reviewed papers, two book chapters, and several abstracts, as well as educational materials for patients. Dr. Comer is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, Vitrectomy, and Cataract Removal. Dr. Comer is board certified in Ophthalmology.

Charles Schultz is a Neurologist and a Sleep Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Schultz is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Migraine, Migraine with Brainstem Aura, Trigeminal Neuralgia, and Sporadic Hemiplegic Migraine. Dr. Schultz is board certified in Neurology.

John K. Fink, MD, is a professor in the Department of Neurology and director of the Neurogenetic Disorders Program in the University of Michigan Medical School. He directs basic science laboratory research focused on identifying genes and mechanisms responsible for age-dependent neurologic degeneration; and on developing treatments for these conditions.Fink's laboratory investigates the molecular basis of inherited neurologic and psychiatric disorders. His clinical expertise focuses on inherited and degenerative disorders of the nervous system. Dr. Fink evaluates individuals of all ages, from infancy through senescence with these disorders, which include lysosomal storage disorders (such as Gaucher disease, Niemann-Pick disease and Fabry disease), ataxias (including Friedreich's ataxia), leukodystrophies (such as Krabbe, CADASIL and adrenoleukodystrophy), familial dystonia, primary lateral sclerosis, Wilson's disease, familial motor neuron disease (including familial amyotrophic lateral sclerosis), familial dementia, and a group of inherited spinal cord disorders known collectively as the Hereditary Spastic Paraplegias (HSPs).Dr. Fink came to the University of Michigan in 1990 as an assistant professor of neurology and director of the Neurogenetic Disorders Clinic. The program provides care and evaluation for individuals and families with inherited and degenerative neurologic disorders; and clinical and molecular laboratory training for physicians and scientists studying these disorders. He was promoted to associate professor in 1996 and professor in 2005.Board-certified in neurology and medical genetics, Dr. Fink received his medical degree in 1980 from the Medical College of Ohio in Toledo. Following internship at the Mayo Clinic in Rochester, Minnesota, he completed a neurology residency in 1984 at the University of Virginia in Charlottesville. Subsequently, he trained in developmental and metabolic neurology and medical genetics at the National Institutes of Health.Dr. Fink has served as the Medical Advisor to the Spastic Paraplegia Foundation since its establishment (2002), and serves as ad hoc reviewer for numerous journals and NIH study sections.A member of the American Society of Human Genetics, American Academy of Neurology, American Neurological Association and the American College of Genetics, Dr. Fink received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2002. In addition, he has been elected by peers to Best Doctors in America annually since 2001. Dr. Fink is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, Primary Lateral Sclerosis, and CACH Syndrome. Dr. Fink is board certified in Clinical Genetics and Neurology.

Shafaq Khairi is an Internal Medicine specialist and an Endocrinologist practicing medicine in Ann Arbor, Michigan. Dr. Khairi is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. She is also highly rated in 40 other conditions, according to our data. Her clinical expertise encompasses Hyperaldosteronism, Familial Hyperaldosteronism, Multiple Endocrine Neoplasia Type 1, and Hyperparathyroidism.

Mark Johnson is an Ophthalmologist practicing medicine in Ann Arbor, Michigan. Dr. Johnson is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Central Serous Chorioretinopathy, and Neuroretinitis.

Scott Bresler is a Pathologist and a Dermatologist practicing medicine in Ann Arbor, Michigan. Dr. Bresler is rated as an Experienced provider by MediFind in the treatment of Tieche-Jadassohn Nevus. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Syringoma, Syringocystadenoma Papilliferum, Sebaceous Adenoma, and Basal Cell Skin Cancer. Dr. Bresler is board certified in Dermatopathology and Pathology-Anatomic/Pathology-Clinical.